跳至主要内容
临床试验/EUCTR2018-004305-11-GB
EUCTR2018-004305-11-GB进行中(未招募)1 期

Salbutamol for analgesia in renal colic: A prospective, randomised, placebo controlled Phase II trial - Salbutamol for Analgesia in Renal Colic (SARC) v1.0

niversity Hospitals of Derby & Burton NHS Foundation Trust0 个研究点目标入组 118 人开始时间: 2019年5月24日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
118

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • 1.Subjects capable of giving informed consent
  • 2.Age =18
  • 3.Working diagnosis of renal colic, as suggested by severe flank/unilateral abdominal pain, +/- radiating to suprapubic/groin area
  • 4.Experiencing severe pain with a requirement for intravenous analgesia
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 118
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • 1.Abdominal aortic aneurysm not yet excluded and participant aged =50
  • 2.Ectopic pregnancy not yet excluded in a female of child-bearing potential
  • 3.Currently actively taking part in another CTIMP
  • 4.Previous participant in this trial
  • 5.Unable to understand verbal and/or written information in English
  • 6.Known allergy to salbutamol
  • 7.Evidence of sepsis or clinical suspicion of urinary tract infection
  • 8.Serum potassium <3.7mmol/l as measured on point-of-care” venous blood gas
  • 9.Concomitant use of: beta blockers (including eye drops); prolonged release opiates; long-acting ß-agonists
  • 10.Use of short-acting ß2-agonists within the 6 hours preceding presentation to the emergency department
  • 11.Current arrhythmia
  • 12.History of any of:
  • ischaemic heart disease
  • arrhythmogenic heart disease
  • valvular heart disease
  • unilateral kidney
  • 13.Any other contraindication to the use of salbutamol

研究者

发起方
niversity Hospitals of Derby & Burton NHS Foundation Trust

相似试验